Steven P. Grahek, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5601 De Soto Ave, Woodland Hills, CA 91367 Phone: 818-719-2000 |
Ritesh Ratilal Bhayani, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5601 De Soto Ave, Woodland Hills, CA 91367 Phone: 818-719-2000 |
Michael Paul Vitullo, D.O. Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 22848 Oxnard St, Woodland Hills, CA 91367 Phone: 818-340-6118 Fax: 818-340-6212 |
Dr. Hamid Ehsani Nia, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21835 Ventura Blvd Ste 21837, Woodland Hills, CA 91364 Phone: 818-600-7348 Fax: 888-972-1912 |
Fausto Farfan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5601 De Soto Ave, Woodland Hills, CA 91367 Phone: 818-719-2000 |
News Archive
Researchers have identified a mechanism by which cells undergo reprogramming in live mice, a phenomenon that had previously been poorly understood.
Groundbreaking new insights on the differences in cardiovascular pathophysiology between women and men will be presented by Marianne Legato, MD, a globally recognized expert in gender specific medicine, and consultant to the Women's Heart Foundation in her keynote address at the 98th Annual American Medical Women's Association Conference in New York City, on March 15-17, 2013.
For patients with cancer, "prehabilitation"— interventions given between the time of diagnosis and the start of treatment—has the potential to reduce complications from treatments and improve physical and mental health outcomes, according to a report in the August American Journal of Physical Medicine & Rehabilitation.
The U.S. Environmental Protection Agency announced the award of a $600,000 research grant to Georgia Tech to improve the detection of known and emerging drinking water contaminants; including the harmful substances produced by blue-green algae in algal blooms and noroviruses.
Anesiva, Inc. today announced that on November 5, 2009, it received a letter from The NASDAQ Stock Market LLC stating that the Nasdaq Hearing Panel has granted Anesiva's request for continued listing on The NASDAQ Global Market subject to the condition that Anesiva shall have completed on or before December 31, 2009, the proposed merger (the "Merger") contemplated by the Agreement and Plan of Merger, dated August 4, 2009, among Anesiva, Arca Acquisition Corporation ("Arca"), a wholly-owned subsidiary of Anesiva, Arcion Therapeutics, Inc. ("Arcion") and, with respect to Articles V and IX only of the agreement, each of the Arcion stockholders listed on Schedule I thereto.
› Verified 9 days ago